comparemela.com

Latest Breaking News On - University of oxford sarah gilbert - Page 1 : comparemela.com

Vacuna de Astrazeneca: la científica que la desarrolló afirma que una dosis de refuerzo es innecesaria

Vacuna de Astrazeneca: la científica que la desarrolló afirma que una dosis de refuerzo es innecesaria
elperiodico.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from elperiodico.com Daily Mail and Mail on Sunday newspapers.

La creadora de la vacuna de AstraZeneca dice que no hacen falta terceras dosis

La creadora de la vacuna de AstraZeneca dice que no hacen falta terceras dosis
lavozdegalicia.es - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lavozdegalicia.es Daily Mail and Mail on Sunday newspapers.

Vaccitech was valued at $ 579 million in the U S public offering

Vaccitech was valued at $ 579 million in the U.S. public offering Vaccitech, the owner of the technology behind the Oxford / AstraZeneca coronavirus vaccine, raised $ 111 million through its initial public offering on Thursday, close to its original expectations and ready for investors to address recent concerns about rare side effects. . The company priced it at $ 17 before it was listed on the Nasdaq, halfway through its projected price range. At the offer price, Vaccitech would be worth $ 579 million, 36 percent above its set price. the last private fundraiser in March. Vaccitech was founded in 2016 by scientists from the University of Oxford Sarah Gilbert and Adrian Hill and is sponsored by Tencent, Google Ventures and California’s Gilead Sciences biotechnologies.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.